VICR vs. VREX, MVIS, PI, AEIS, UDMY, UPWK, GETY, SGML, IONQ, and LILA
Should you be buying Vicor stock or one of its competitors? The main competitors of Vicor include Varex Imaging (VREX), MicroVision (MVIS), Impinj (PI), Advanced Energy Industries (AEIS), Udemy (UDMY), Upwork (UPWK), Getty Images (GETY), Sigma Lithium (SGML), IonQ (IONQ), and Liberty Latin America (LILA).
Varex Imaging (NASDAQ:VREX) and Vicor (NASDAQ:VICR) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, media sentiment, earnings, community ranking, analyst recommendations, profitability and risk.
Vicor has lower revenue, but higher earnings than Varex Imaging. Varex Imaging is trading at a lower price-to-earnings ratio than Vicor, indicating that it is currently the more affordable of the two stocks.
47.5% of Vicor shares are owned by institutional investors. 5.2% of Varex Imaging shares are owned by insiders. Comparatively, 31.3% of Vicor shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Vicor has a net margin of 13.23% compared to Vicor's net margin of 5.08%. Varex Imaging's return on equity of 10.45% beat Vicor's return on equity.
In the previous week, Vicor had 2 more articles in the media than Varex Imaging. MarketBeat recorded 4 mentions for Vicor and 2 mentions for Varex Imaging. Varex Imaging's average media sentiment score of 0.10 beat Vicor's score of -0.99 indicating that Vicor is being referred to more favorably in the news media.
Vicor received 5 more outperform votes than Varex Imaging when rated by MarketBeat users. However, 63.64% of users gave Varex Imaging an outperform vote while only 60.67% of users gave Vicor an outperform vote.
Varex Imaging has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500. Comparatively, Vicor has a beta of 1.53, suggesting that its stock price is 53% more volatile than the S&P 500.
Varex Imaging presently has a consensus target price of $27.00, indicating a potential upside of 58.92%. Vicor has a consensus target price of $57.50, indicating a potential upside of 69.77%. Given Varex Imaging's higher probable upside, analysts plainly believe Vicor is more favorable than Varex Imaging.
Summary
Vicor beats Varex Imaging on 14 of the 18 factors compared between the two stocks.
Get Vicor News Delivered to You Automatically
Sign up to receive the latest news and ratings for VICR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VICR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools